FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550403306> ?p ?o ?g. }

• W2550403306 abstract "Background Diffuse cutaneous systemic sclerosis (dcSSc) is a severe subset of SSc, a chronic rare autoimmune connective tissue disease associated with high morbidity and mortality, and reduced quality of life. There are few treatments approved for dcSSc. Using semi-structured discussions, our objective was to gain better insight into clinical practice regarding referral and diagnosis of patients with dcSSc in different geographic regions. Methods Physicians participated in 60- or 30-minute interviews, following a discussion outline, to determine how dcSSc patient care is structured in the USA and EU. Physicians were asked to identify key steps in the patient pathway, typical patient presentation, and the diagnostic, treatment, and follow-up processes used, and those responsible for their implementation. Results Physicians in six countries (France, Germany, Italy, Spain, UK, and USA) were interviewed; 84 60-minute interviews with rheumatologists (or internal medicine specialists in France), and 40 30-minute interviews with dermatologists were conducted. Patient care was coordinated mostly by rheumatologists (except in France, where internal medicine specialists can be responsible), or to a lesser degree by dermatologists (in Germany, France, Italy) (Figure). Specialist centers are not well defined, and do not exist in all countries; therefore, most patients continued their treatment in the hospital where first diagnosed. Patients were slow to present to primary healthcare providers (HCPs), with presentation taking on average 6 months to 1 year, as they considered very early dcSSc symptoms to be trivial. Once referred to a rheumatologist, clinical evaluation and antibody testing led to quick diagnosis; however, dcSSc awareness among primary HCPs is variable, and delayed referral to a rheumatologist is common. Use of the 2013 ACR/EULAR updated classification of SSc, and the modified Rodnan skin score (mRSS) were limited to specialist centers and clinical trials, rather than daily practice, although physicians follow a similar diagnostic process. Where mRSS was measured (n=46 in this survey, predominantly by rheumatologists), patients had an mRSS of 10–22 at diagnosis, and >50% of diagnosed patients had an mRSS of ≥15. Physicians were vigilant for signs of organ involvement, but the priority given to skin changes differed according to specialty. Conclusions Improved patient and primary HCP awareness of dcSSc could lead to earlier referral to a rheumatologist or dermatologist and the avoidance of delayed diagnosis. Specialized centers need better definition in most countries. Use of the mRSS at diagnosis and follow-up may help to monitor disease progression. Disclosure of Interest D. Khanna Grant/research support from: NIH/NIAMS, NIH/ NIAID, Bayer, BMS, Consultant for: Bayer, BMS, Genetech/Roche, GSK, Genkyotex, Sanofi-Aventis, Actelion, Gilead, Employee of: University of Michigan, Y. Allanore Grant/research support from: Bristol-Myers Squibb, Roche/Genentech, Inventiva, Pfizer, Sanofi, Servier, Consultant for: Actelion, Bayer, Roche/Genentech, Inventiva, Medac, Pfizer, Sanofi, Servier, UCB, C. Denton Grant/research support from: Actelion, GSK, Novartis, CSL Behring, Consultant for: Bayer, Roche, GSK, Actelion, Inventiva, CSL Behring, Takeda, Merck-Serono, Medimmune, Biogen, M. Matucci-Cerinic Consultant for: Actelion, GSK, Pfizer, BMS, J. Pope Grant/research support from: Actelion, Bayer, Consultant for: Actelion, Bayer, B. Hinzmann Shareholder of: Bayer Pharma AG, Employee of: Bayer Pharma AG, S. Briody: None declared, J. de Oliveira Pena Employee of: Bayer HealthCare Pharmaceuticals Inc., O. Distler Grant/research support from: Actelion, Pfizer, Sanofi-Aventis, Bayer, Consultant for: Ergonex, United BioSource, Biovitrium, Novartis, Biogen Idec, Inventiva" @default.
• W2550403306 created "2016-11-30" @default.
• W2550403306 creator A5005771236 @default.
• W2550403306 creator A5006873131 @default.
• W2550403306 creator A5023213876 @default.
• W2550403306 creator A5039032334 @default.
• W2550403306 creator A5047217681 @default.
• W2550403306 creator A5048430823 @default.
• W2550403306 creator A5059359523 @default.
• W2550403306 creator A5073269240 @default.
• W2550403306 creator A5082406917 @default.
• W2550403306 date "2016-06-01" @default.
• W2550403306 modified "2023-10-18" @default.
• W2550403306 title "FRI0269 Diffuse Cutaneous Systemic Sclerosis (dcSSc) Referral and Diagnosis: Results of A Survey of Healthcare Providers" @default.
• W2550403306 doi "https://doi.org/10.1136/annrheumdis-2016-eular.3529" @default.
• W2550403306 hasPublicationYear "2016" @default.
• W2550403306 type Work @default.
• W2550403306 sameAs 2550403306 @default.
• W2550403306 citedByCount "0" @default.
• W2550403306 crossrefType "journal-article" @default.
• W2550403306 hasAuthorship W2550403306A5005771236 @default.
• W2550403306 hasAuthorship W2550403306A5006873131 @default.
• W2550403306 hasAuthorship W2550403306A5023213876 @default.
• W2550403306 hasAuthorship W2550403306A5039032334 @default.
• W2550403306 hasAuthorship W2550403306A5047217681 @default.
• W2550403306 hasAuthorship W2550403306A5048430823 @default.
• W2550403306 hasAuthorship W2550403306A5059359523 @default.
• W2550403306 hasAuthorship W2550403306A5073269240 @default.
• W2550403306 hasAuthorship W2550403306A5082406917 @default.
• W2550403306 hasConcept C141071460 @default.
• W2550403306 hasConcept C160735492 @default.
• W2550403306 hasConcept C162324750 @default.
• W2550403306 hasConcept C187212893 @default.
• W2550403306 hasConcept C2776135927 @default.
• W2550403306 hasConcept C2777601897 @default.
• W2550403306 hasConcept C50522688 @default.
• W2550403306 hasConcept C512399662 @default.
• W2550403306 hasConcept C71924100 @default.
• W2550403306 hasConceptScore W2550403306C141071460 @default.
• W2550403306 hasConceptScore W2550403306C160735492 @default.
• W2550403306 hasConceptScore W2550403306C162324750 @default.
• W2550403306 hasConceptScore W2550403306C187212893 @default.
• W2550403306 hasConceptScore W2550403306C2776135927 @default.
• W2550403306 hasConceptScore W2550403306C2777601897 @default.
• W2550403306 hasConceptScore W2550403306C50522688 @default.
• W2550403306 hasConceptScore W2550403306C512399662 @default.
• W2550403306 hasConceptScore W2550403306C71924100 @default.
• W2550403306 hasLocation W25504033061 @default.
• W2550403306 hasOpenAccess W2550403306 @default.
• W2550403306 hasPrimaryLocation W25504033061 @default.
• W2550403306 hasRelatedWork W2079746720 @default.
• W2550403306 hasRelatedWork W2256472928 @default.
• W2550403306 hasRelatedWork W2315192053 @default.
• W2550403306 hasRelatedWork W2331477702 @default.
• W2550403306 hasRelatedWork W2552918916 @default.
• W2550403306 hasRelatedWork W2756073008 @default.
• W2550403306 hasRelatedWork W2949592761 @default.
• W2550403306 hasRelatedWork W2950300273 @default.
• W2550403306 hasRelatedWork W2952566230 @default.
• W2550403306 hasRelatedWork W2953076302 @default.
• W2550403306 hasRelatedWork W3034033085 @default.
• W2550403306 hasRelatedWork W3034264855 @default.
• W2550403306 hasRelatedWork W3037351371 @default.
• W2550403306 hasRelatedWork W3043240276 @default.
• W2550403306 hasRelatedWork W3046369104 @default.
• W2550403306 hasRelatedWork W3080582006 @default.
• W2550403306 hasRelatedWork W3124649909 @default.
• W2550403306 hasRelatedWork W3164993103 @default.
• W2550403306 hasRelatedWork W3165295752 @default.
• W2550403306 hasRelatedWork W3165606540 @default.
• W2550403306 isParatext "false" @default.
• W2550403306 isRetracted "false" @default.
• W2550403306 magId "2550403306" @default.
• W2550403306 workType "article" @default.